Download PDF
Thromb Haemost 1993; 69(04): 339-343
DOI: 10.1055/s-0038-1651609
Original Article
Coagulation
Schattauer GmbH Stuttgart

The Pharmacokinetics of LMW Dermatan Sulphate: Long-Term Persistence of Intact Material

Joan Dawes
The Heart Research Institute, Sydney, Australia
› Author Affiliations
Further Information

Publication History

Received 28 April 1992

Accepted after revision 01 December 1992

Publication Date:
05 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

An iodinated derivative of the low molecular weight dermatan sulphate Desmin 370 was administered to rats by intravenous, subcutaneous and intramuscular routes in conjunction with unlabelled Desmin 370. Following intravenous injection radiolabel was cleared from the plasma according to a tri-exponential function with elimination half-lives of 45 min and 13 h; there was a high concentration in tissues, particularly the kidney, compared with plasma. The apparent bioavailability following s. c. injection was 52-65%, but 84-100% after i. m. administration. Undegraded as well as desulphated molecules were identified in plasma, and intact 125I-Desmin 370 comprised > 85% of the radiolabel in urine 48 h post-injection. Thus intact Desmin 370 persists for a long period after a single injection. The pharmacological significance of these findings, however, remainsto be determined.

 

  • References

  • 1 Tollefsen DM, Pestka CA, Monafo WJ. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 1983; 258: 6713-6716
    PubMedGoogle Scholar
  • 2 Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA. Heparin sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Blood 1984; 64: 742-747
    PubMedGoogle Scholar
  • 3 Buchanan MR, Boneu B, Ofosu FA, Hirsh J. The relative importance of thrombin and factor Xa inhibition to the antithrombotic effects of heparin. Blood 1985; 65: 198-201
    PubMedGoogle Scholar
  • 4 Maggi A, Abbadini M, Pagella PG, Borowska A, Pangrazzi J, Donati MB. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model. Haemostasis 1987; 17: 329-335
    PubMedGoogle Scholar
  • 5 Van Ryn-McKenna J, Gray E, Weber E, Ofosu FA, Buchanan MR. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli. Thromb Haemostas 1989; 61: 7-9
    PubMedGoogle Scholar
  • 6 Van Ryn-McKenna J, Ofosu FA, Gray E, Hirsh J, Buchanan MR. The effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo. Ann NY Acad Sci 1989; 556: 304-312
    CrossrefPubMedGoogle Scholar
  • 7 Barbanti M, Calanni F, Milani MR, Marchi E, Semeraro N, Colucci M. Therapeutic effect of a low molecular weight dermatan sulphate (Desmin 370) in rat venous thrombosis. Evidence for an anticoagulant-independent mechanism. Thromb Haemostas 1993; 69: 147-151
    PubMedGoogle Scholar
  • 8 Sié P, Fernandez F, Caranobe C, Gabaig AM, Boneu B. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate. Thromb Res 1982; 35: 231-236
    PubMedGoogle Scholar
  • 9 Fernandez F, van Ryn J, Ofosu FA, Hirsh J, Buchanan MR. The haemorrhagic and antithrombotic effects of dermatan sulphate. Br J Haematol 1986; 64: 309-317
    CrossrefPubMedGoogle Scholar
  • 10 Dawes J, Hodson BA, MacGregor IR, Pepper DS, Prowse CV. Pharmacokinetics and biological activities of dermatan sulphate (Mediolanum MF701) in healthy human volunteers. Ann NY Acad Sci 1989; 556: 292-303
    CrossrefPubMedGoogle Scholar
  • 11 Dol F, Houin G, Rostin M, Montastruc JL, Dupouy F, Gianese F, Sié P, Boneu B. Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans. Blood 1989; 74: 1577-1582
    PubMedGoogle Scholar
  • 12 Dawes J, McLaren M, Forbes C, Belch JJF, Lane DA, Bray B, McEwen J, Houin G, Gianese F. The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers. Br J Clin Pharmacol 1991; 32: 361-366
    CrossrefPubMedGoogle Scholar
  • 13 Dawes J, Prowse CV, Pepper DS. Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assay. Thromb Res 1986; 44: 683-693
    CrossrefPubMedGoogle Scholar
  • 14 Dol F, Petitou M, Lormeau JC, Choay J, Caranobe C, Sié P, Saivin S, Houin G, Boneu B. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate. J Lab Clin Med 1990; 115: 43-51
    PubMedGoogle Scholar
  • 15 European patent no. 221977. Trough Chem Abstr 1990; 107: 78204
    PubMed
  • 16 Dawes J, Pepper DS. Catabolism of low dose heparin in man. Thromb Res 1979; 14: 845-860
    CrossrefPubMedGoogle Scholar
  • 17 Greenwood FC, Hunter WM, Glover JS. The preparation of 311I-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 14: 114-123
    PubMedGoogle Scholar
  • 18 Lam LH, Silbert JE, Rosenberg RD. The separation of active and inactive forms of heparin. Biochem Biophys Res Commun 1976; 69: 570-577
    CrossrefPubMedGoogle Scholar
  • 19 Dawes J, Prowse CV, Pepper DS. The measurement of heparin and other therapeutic sulphated polysaccharides in plasma, serum and urine. Thromb Haemostas 1985; 54: 630-634
    PubMedGoogle Scholar
  • 20 Dawes J, Hodson BA, Pepper DS. The absorption, clearance and metabolic fate of dermatan sulphate administered to man – studies using a radioiodinated derivative. Thromb Haemostas 1989; 62: 945-949
    PubMedGoogle Scholar
  • 21 Boneu B, Buchanan MR, Caranobe C, Gabaig AM, Dupouy D, Sié P, Hirsh J. The disappearance of a low molecular weight heparin fraction (CY216) differs from standard heparin in rabbits. Thromb Res 1987; 46: 845-853
    CrossrefPubMedGoogle Scholar
  • 22 Bergonzini GL, Bianchini P, Hoppensteadt D, Parma B, Osima B, Walenga JM, Fareed J. Pharmacokinetics of native and low molecular weight dermatans: preliminary studies in rats and primates. Semin Thromb Hemostas 1991; 17 (Suppl. 02) 235-239
    PubMedGoogle Scholar